Download
11060_2024_Article_4547.pdf 1,49MB
WeightNameValue
1000 Titel
  • Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment
1000 Autor/in
  1. Obrecht-Sturm, Denise |
  2. Pfaff, Elke |
  3. Mynarek, Martin |
  4. Bison, Brigitte |
  5. Rodehüser, Martina |
  6. Becker, Martina |
  7. Kietz, Silke |
  8. Pfister, Stefan M. |
  9. Jones, David T. |
  10. Sturm, Dominik |
  11. von Deimling, Andreas |
  12. Sahm, Felix |
  13. Kortmann, Rolf-Dieter |
  14. Schwarz, Rudolf |
  15. Pietsch, Torsten |
  16. Fleischhack, Gudrun |
  17. Rutkowski, Stefan |
1000 Verlag Springer US
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-01-22
1000 Erschienen in
1000 Quellenangabe
  • 166(2):359-368
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s11060-023-04547-5 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10834633/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Purpose</jats:title> <jats:p>To provide a treatment-focused review and develop basic treatment guidelines for patients diagnosed with pineal anlage tumor (PAT).</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>Prospectively collected data of three patients with pineal anlage tumor from Germany was combined with clinical details and treatment information from 17 published cases.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>Overall, 20 cases of PAT were identified (3 not previously reported German cases, 17 cases from published reports). Age at diagnosis ranged from 0.3 to 35.0 (median: 3.2 ± 7.8) years. All but three cases were diagnosed before the age of three years. For three cases, metastatic disease at initial staging was described. All patients underwent tumor surgery (gross-total resection: 9, subtotal resection/biopsy: 9, extent of resection unknown: 2). 15/20 patients were alive at last follow-up. Median follow-up for 10/15 surviving patients with available follow-up and treatment data was 2.4 years (0.3–6.5). Relapse was reported for 3 patients within 0.8 years after diagnosis. Five patients died, 3 after relapse and 2 from early postoperative complications. Two-year-progression-free- and -overall survival were 65.2 ± 12.7% and 49.2 ± 18.2%, respectively. All 4 patients who received intensive chemotherapy including high-dose chemotherapy combined with radiotherapy (2 focal, 2 craniospinal [CSI]) had no recurrence. Focal radiotherapy- and CSI-free survival rates in 13 evaluable patients were 46.2% (6/13) and 61.5% (8/13), respectively.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>PAT is an aggressive disease mostly affecting young children. Therefore, adjuvant therapy using intensive chemotherapy and considering radiotherapy appears to comprise an appropriate treatment strategy. Reporting further cases is crucial to evaluate distinct treatment strategies.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Adolescent [MeSH]
lokal Pinealoma/diagnosis [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Supratentorial Neoplasms/pathology [MeSH]
lokal PINEAL anlage tumor
lokal Treatment Outcome [MeSH]
lokal Brain Neoplasms/surgery [MeSH]
lokal Case Study
lokal Neoplasm Recurrence, Local/pathology [MeSH]
lokal Pinealoma/surgery [MeSH]
lokal Recurrence [MeSH]
lokal Pineal gland
lokal Infant [MeSH]
lokal Young Adult [MeSH]
lokal Brain Neoplasms/diagnosis [MeSH]
lokal Pineal Gland/pathology [MeSH]
lokal Child [MeSH]
lokal Pineoblastoma
lokal Pineal Gland/surgery [MeSH]
lokal Child, Preschool [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-3216-8452|https://frl.publisso.de/adhoc/uri/UGZhZmYsIEVsa2U=|https://frl.publisso.de/adhoc/uri/TXluYXJlaywgTWFydGlu|https://frl.publisso.de/adhoc/uri/Qmlzb24sIEJyaWdpdHRl|https://frl.publisso.de/adhoc/uri/Um9kZWjDvHNlciwgTWFydGluYQ==|https://frl.publisso.de/adhoc/uri/QmVja2VyLCBNYXJ0aW5h|https://frl.publisso.de/adhoc/uri/S2lldHosIFNpbGtl|https://frl.publisso.de/adhoc/uri/UGZpc3RlciwgU3RlZmFuIE0u|https://frl.publisso.de/adhoc/uri/Sm9uZXMsIERhdmlkIFQu|https://frl.publisso.de/adhoc/uri/U3R1cm0sIERvbWluaWs=|https://frl.publisso.de/adhoc/uri/dm9uIERlaW1saW5nLCBBbmRyZWFz|https://frl.publisso.de/adhoc/uri/U2FobSwgRmVsaXg=|https://frl.publisso.de/adhoc/uri/S29ydG1hbm4sIFJvbGYtRGlldGVy|https://frl.publisso.de/adhoc/uri/U2Nod2FyeiwgUnVkb2xm|https://frl.publisso.de/adhoc/uri/UGlldHNjaCwgVG9yc3Rlbg==|https://frl.publisso.de/adhoc/uri/RmxlaXNjaGhhY2ssIEd1ZHJ1bg==|https://frl.publisso.de/adhoc/uri/UnV0a293c2tpLCBTdGVmYW4=
1000 Hinweis
  • DeepGreen-ID: e84e0a7fce4e4c93b5be8c627fab5a35 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. German Children’s Cancer Foundation |
  2. Universitätsklinikum Hamburg-Eppendorf (UKE) |
1000 Fördernummer
  1. -
  2. -
1000 Förderprogramm
  1. -
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer German Children’s Cancer Foundation |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Universitätsklinikum Hamburg-Eppendorf (UKE) |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6503381.rdf
1000 Erstellt am 2025-02-05T20:40:45.203+0100
1000 Erstellt von 322
1000 beschreibt frl:6503381
1000 Zuletzt bearbeitet 2025-08-05T07:46:29.132+0200
1000 Objekt bearb. Tue Aug 05 07:46:29 CEST 2025
1000 Vgl. frl:6503381
1000 Oai Id
  1. oai:frl.publisso.de:frl:6503381 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source